LOMBARDI, Silvia
 Distribuzione geografica
Continente #
NA - Nord America 1.148
AS - Asia 417
EU - Europa 350
AF - Africa 5
SA - Sud America 3
OC - Oceania 1
Totale 1.924
Nazione #
US - Stati Uniti d'America 1.141
CN - Cina 148
IT - Italia 147
SG - Singapore 125
DE - Germania 57
ID - Indonesia 48
TR - Turchia 32
FI - Finlandia 26
SE - Svezia 23
UA - Ucraina 22
GB - Regno Unito 17
HK - Hong Kong 12
PL - Polonia 10
IR - Iran 9
BE - Belgio 8
CZ - Repubblica Ceca 8
IQ - Iraq 8
JP - Giappone 8
CA - Canada 7
FR - Francia 7
IN - India 6
NO - Norvegia 6
KR - Corea 5
PT - Portogallo 5
NL - Olanda 4
TW - Taiwan 4
BR - Brasile 3
DK - Danimarca 3
GE - Georgia 3
PK - Pakistan 3
EG - Egitto 2
IL - Israele 2
NG - Nigeria 2
RO - Romania 2
VN - Vietnam 2
AT - Austria 1
AU - Australia 1
CH - Svizzera 1
EE - Estonia 1
KG - Kirghizistan 1
LV - Lettonia 1
MY - Malesia 1
RU - Federazione Russa 1
ZA - Sudafrica 1
Totale 1.924
Città #
Chandler 177
Santa Clara 140
Singapore 110
Fairfield 103
Ashburn 61
Ferrara 53
Woodbridge 50
Jakarta 47
Houston 43
Ann Arbor 41
Cambridge 36
New York 36
Seattle 35
Princeton 34
Wilmington 34
Shanghai 29
Izmir 27
Milan 26
Helsinki 23
Beijing 22
Bremen 21
Jacksonville 20
Nanjing 19
Los Angeles 16
Redwood City 13
Dearborn 11
Warsaw 10
Ferrara di Monte Baldo 8
Hebei 8
Baghdad 7
Bologna 7
Brussels 7
San Diego 7
Boardman 6
Brno 6
Falkenstein 6
Guangzhou 6
Hong Kong 5
Nanchang 5
Piemonte 5
Rome 5
Cagliari 4
Chicago 4
Rochester 4
San Mateo 4
Shenyang 4
Toronto 4
Copenhagen 3
Frankfurt am Main 3
Islamabad 3
Jiaxing 3
London 3
Munich 3
Norwalk 3
Oslo 3
Racale 3
Silveira 3
Taipei 3
Tianjin 3
Washington 3
Zhengzhou 3
Alexandria 2
Andover 2
Augusta 2
Belvedere Spinello 2
Changsha 2
Cheltenham 2
Clifton 2
Des Moines 2
Dong Ket 2
Duncan 2
Falls Church 2
Florence 2
Hangzhou 2
Henderson 2
Ithaca 2
Jinan 2
Kunming 2
Lagos 2
Leawood 2
Lucknow 2
Minya 2
Monmouth Junction 2
Naples 2
Ningbo 2
Nottingham 2
Noventa Vicentina 2
Ottawa 2
Padova 2
Philadelphia 2
Ponticelli 2
Reggio Emilia 2
Sabz 2
Semnan 2
Seocho-gu 2
Shenzhen 2
Tabriz 2
Tel Aviv 2
Worcester 2
Ambrolauri 1
Totale 1.468
Nome #
Differential functional readthrough over homozygous nonsense mutations contributes to the bleeding phenotype in coagulation factor VII deficiency 175
Responsiveness of hemophilia B- causing non sense mutations to ribosome readthrough-inducing drugs strictly depends on the nucleotide and prrotein context 136
The chaperone-like sodium phenylbutyrate improves factor IX intracellular trafficking and activity impaired by the frequent p.R294Q mutation 118
The carboxyl-terminal region of human coagulation factor X as a natural linker for fusion strategies 108
Translational readthrough of GLA nonsense mutations suggests dominant-negative effects exerted by the interaction of wild-type and missense variants 81
The carboxyl-terminal region of human coagulation factor X as a novel naturally-occuring linker for fusion strategies 81
A strategy with chaperone-like compounds to restore expression of factor IX variants affected by frequent missense mutations causing hemophilia B 78
The chaperone-like compound sodium phenylbutyrate improves intracellular trafficking, secretion and coagulant activity of factor IX impaired by the frequent p.R294Q mutation 74
A Compensatory U1snRNA Partially Rescues FAH Splicing and Protein Expression in a Splicing-Defective Mouse Model of Tyrosinemia Type I 73
An exon-specific small nuclear u1 rna (Exspeu1) improves hepatic otc expression in a splicing-defective spf /ash mouse model of ornithine transcarbamylase deficiency 64
A next-generation rFVIIa fusion protein with enhanced half-life as a novel by-passing tool in hemophilia 64
Exploring chaperone-like compounds as innovative therapeutic correction approach for factor IX missense mutations causing type I Haemophilia B 62
Exon-Specific U1snRNA-Mediated Rescue of Splicing and Missense Changes in Hemophilia A 61
An engineered human albumin enhances half-life and transmucosal delivery when fused to protein-based biologics 60
Fusion of engineered albumin with factor IX Padua extends half-life and improves coagulant activity 59
Rational engineering of a novel factor IX albumin fusion protein results in enhanced coagulant activity and pharmacokinetic profile 57
Exploring spontaneous readthrough over recurrent F8 nonsense mutations: potential correlation with inhibitor risk? 57
Molecular insights into determinants of translational readthrough and implications for nonsense suppression approaches 54
Exploring chaperone-like compounds as innovative therapeutic strategy for Hemophilia B 52
Dissection of pleiotropic effects of variants in and adjacent to F8 exon 19 and rescue of mRNA splicing and protein function 52
Translation termination codons in protein synthesis and disease 51
Design of a novel factor IX albumin fusion protein with enhanced coagulant activity and pharmacokinetic profile 51
Readthrough-mediated functional suppression of homozygous nonsense mutations accounts for variable bleeding phenotypes in factor VII deficiency 49
Detection of Residual Factor VIII Levels Reveals the Occurrence of Readthrough Over the Majority of F8 Nonsense Mutations 49
Targeted molecular strategies for X-linked genetic disorders: the paradigmatic models of Fabry disease and Haemophilias 49
Design of a novel factor IX variant with enhanced procoagulant activity and half-life 42
Spontaneous readthrough over recurrent F8 nonsense mutations is associated with residual factor VIII levels: implications for inhibitor risk? 41
Deep molecular mechanisms of F8 exon 19 variants and translational approaches in Hemophilia A 37
Comparative Analysis Of Residual Factor VIII Expression from Recurrent F8 Nonsense Mutations Indicates that Localization in the B- domain Favours Readthrough- mediated Protein Output 35
Translational readthrough at F8 nonsense variants in the factor VIII B domain contributes to residual expression and lowers inhibitor association 35
Rescue of multiple Haemophilia A-causing mutations by a single ExSpeU1: the importance of the genomic context 30
Totale 2.035
Categoria #
all - tutte 13.411
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 299
Totale 13.710


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020113 0 0 0 0 0 27 23 19 20 10 9 5
2020/2021242 7 5 9 14 13 28 31 46 9 21 32 27
2021/2022280 52 34 10 4 20 14 7 7 8 20 19 85
2022/2023372 30 49 10 53 55 38 30 22 52 3 17 13
2023/2024255 9 21 12 4 13 49 9 23 8 15 11 81
2024/2025414 32 17 85 23 109 148 0 0 0 0 0 0
Totale 2.035